Richard W. Keen
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.
Journal: JAMA
Published: May 14, 2026
Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.
Journal: European journal of endocrinology
Published: January 20, 2026
Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.
Journal: European journal of endocrinology
Published: January 20, 2026
Content Validation of the Flares Diary: A Qualitative Analysis of the Flares Experience Within the Fibrodysplasia Ossificans Progressiva (FOP) Population.
Journal: Advances in therapy
Published: November 17, 2025
Quantitative Sensory Testing Reveals Evidence of Altered Pain Processing in Paget's Disease of Bone.
Quantitative Sensory Testing Reveals Evidence of Altered Pain Processing in Paget's Disease of Bone.
Journal: Calcified tissue international
Published: September 08, 2025
Medical guidelines for fibrodysplasia ossificans progressiva.
Journal: JBMR plus
Published: August 04, 2025
Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta.
Journal: Calcified tissue international
Published: July 05, 2025
Real-World Effectiveness of Burosumab in Adults with X-Linked Hypophosphataemia (XLH) in the UK.
Journal: Calcified tissue international
Published: June 05, 2025
Palovarotene in fibrodysplasia ossificans progressiva: review and perspective.
Journal: Expert opinion on pharmacotherapy
Published: January 21, 2025
Mobility and Quality of Life in Adults with Paediatric-Onset Hypophosphatasia Treated with Asfotase Alfa: Results from UK Managed Access Agreement.
Journal: Advances in therapy
Published: January 07, 2025
Burosumab for X-linked Hypophosphataemia and Tumour-induced Osteomalacia in Adults.
Journal: TouchREVIEWS in endocrinology
Published: November 27, 2024
Pharmacological and non-pharmacological therapies for prevention and treatment of osteoporosis in Duchenne Muscular Dystrophy: A systematic review.
Journal: Bone
Published: November 08, 2024
Last Updated: 09/26/2026